Publication: [Health-related quality of life in patients consuming benzodiazepine].
dc.contributor.author | García Atienza, Eva María | |
dc.contributor.author | López-Torres Hidalgo, Jesús | |
dc.contributor.author | Minuesa García, María | |
dc.contributor.author | Ruipérez Moreno, María | |
dc.contributor.author | Lucas Galán, Francisco Javier | |
dc.contributor.author | Agudo Mena, José Luis | |
dc.date.accessioned | 2023-02-09T10:47:29Z | |
dc.date.available | 2023-02-09T10:47:29Z | |
dc.date.issued | 2021-03-26 | |
dc.description.abstract | To describe the health-related quality of life (HRQoL) in benzodiazepine users and to verify whether there is an association with the characteristics of the treatment, its effectiveness, and the sociodemographic variables. Descriptive cross-sectional study. Family medicine consultations. Four hundred and fifty 2patients over 18 years of age consuming benzodiazepines or similar drugs. HRQoL was assessed using the EuroQol5-D questionnaire. Other variables: symptoms of anxiety or insomnia, sociodemographic variables and characteristics of the treatment. The mean score in health status was 62.80 (95% CI: 60.69-64.86), lower in people without studies (59.27±21.97 SD; P=.004) and lower social category (60.02±21.27 SD; P Patients who use benzodiazepines show, despite treatment, a moderate HRQL, lower than that obtained in the general population or in primary care patients. The situation is more favorable in the youngest, in those who do not present anxiety/insomnia, in those belonging to higher social classes and when the consumption of drugs is lower. | |
dc.identifier.doi | 10.1016/j.aprim.2021.102041 | |
dc.identifier.essn | 1578-1275 | |
dc.identifier.pmc | PMC8041718 | |
dc.identifier.pmid | 33780900 | |
dc.identifier.pubmedURL | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8041718/pdf | |
dc.identifier.unpaywallURL | https://doi.org/10.1016/j.aprim.2021.102041 | |
dc.identifier.uri | http://hdl.handle.net/10668/17420 | |
dc.issue.number | 5 | |
dc.journal.title | Atencion primaria | |
dc.journal.titleabbreviation | Aten Primaria | |
dc.language.iso | es | |
dc.organization | Metropolitano de Granada | |
dc.page.number | 102041 | |
dc.pubmedtype | Journal Article | |
dc.rights | Attribution-NonCommercial-NoDerivatives 4.0 International | |
dc.rights.accessRights | open access | |
dc.rights.uri | http://creativecommons.org/licenses/by-nc-nd/4.0/ | |
dc.subject | Benzodiacepinas | |
dc.subject | Benzodiazepines | |
dc.subject | Calidad de vida relacionada con la salud | |
dc.subject | EQ-5D | |
dc.subject | Estado de salud percibido | |
dc.subject | Health-related quality of life | |
dc.subject | Perceived state of health | |
dc.subject.mesh | Adolescent | |
dc.subject.mesh | Adult | |
dc.subject.mesh | Aged | |
dc.subject.mesh | Benzodiazepines | |
dc.subject.mesh | Cross-Sectional Studies | |
dc.subject.mesh | Health Status | |
dc.subject.mesh | Humans | |
dc.subject.mesh | Quality of Life | |
dc.subject.mesh | Surveys and Questionnaires | |
dc.title | [Health-related quality of life in patients consuming benzodiazepine]. | |
dc.title.alternative | Calidad de vida relacionada con la salud en pacientes consumidores de benzodiacepinas. | |
dc.type | research article | |
dc.type.hasVersion | VoR | |
dc.volume.number | 53 | |
dspace.entity.type | Publication |
Files
Original bundle
1 - 1 of 1